New scan may reveal if cancer drug will work before treatment starts
NCT ID NCT02226276
Summary
This small study is testing a new type of PET scan to see if it can predict which patients with advanced HER2-positive breast cancer will benefit from a specific drug treatment. Researchers attach a tiny radioactive tag to a cancer drug and use a scanner to see where it goes in the body. The goal is to help doctors choose the right treatment for each patient by seeing how the cancer absorbs the drug before starting full therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
Conditions
Explore the condition pages connected to this study.